MiNK Therapeutics/$INKT
About MiNK Therapeutics
Ticker
Industry
Employees
INKT Metrics
$31M
-
-$0.38
0.05
-
Price and volume
Market cap
$31M
Beta
0.05
52-week high
$1.90
52-week low
$0.46
Average daily volume
154K
Financial strength
Current ratio
0.889
Quick ratio
0.855
Long term debt to equity
-26.271
Total debt to equity
-26.271
Management effectiveness
Return on assets (TTM)
-120.36%
Return on equity (TTM)
88.52%
Valuation
Price to book
-1.74
Price to tangible book (TTM)
-1.74
Price to free cash flow (TTM)
-2.598
Growth
Earnings per share change (TTM)
-47.88%
3-year earnings per share growth (CAGR)
-29.42%
What the Analysts think about INKT
Analyst Ratings
INKT Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
INKT Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
INKT News
MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting
MiNK Therapeutics, Inc. (INKT) Q3 2024 Earnings Conference Call Transcript
MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report
FAQs
What’s the current market cap for MiNK Therapeutics stock?
What is the P/E ratio for MiNK Therapeutics stock?
Does MiNK Therapeutics stock pay dividends?
No, MiNK Therapeutics (INKT) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next MiNK Therapeutics dividend payment date?
MiNK Therapeutics (INKT) stock does not pay dividends to its shareholders.
What is the beta indicator for MiNK Therapeutics?
MiNK Therapeutics (INKT) has a beta rating of 0.05. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.